Collaborative Care for Anxiety and Depression in Epilepsy
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT05559749
- Status
- Recruiting
Conditions
- Anxiety
- Depression
- Epilepsy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- collaborative care — BEHAVIORALa 24-week neurology based collaborative care program consisting of: 1. a series of every 2 weeks care management calls by the care manager to evaluate anxiety, depression, seizures and side effects and deliver brief therapy interventions to the participant, and 2. collaborative care conferences including a psychiatrist to generate expert recommendations for anxiety and depression management and communication of recommendations between the care manger, psychiatrist and neurologist.
- usual neurology care — BEHAVIORALongoing usual neurology care, without the addition of the collaborative care program
Study Details
This is a randomized effectiveness/implementation trial comparing a 24-week neurology-based collaborative care intervention to usual neurology care among 60 adults with epilepsy.
Key Dates
- Start date
- May 4, 2023
- Status verified
- Jan 2026
- Primary completion
- Feb 19, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: collaborative careThe collaborative care team roles include the care manager/social worker and psychiatrist who interact with the patient participant and the patient's neurologist/neurology provider.
- Active Comparator: usual neurology careOngoing usual neurology care, without the addition of the collaborative care program - current standard care and is thus an ethically appropriate control condition for effectiveness and implementation trials.
Primary Outcome Measure
change in emotional quality of life subscale of the Quality of Life in Epilepsy Inventory (QOLIE-31) - between two groups [ Time Frame: Month 6 ]
Central Contacts
- Lauren P Richmond336.716.9632
- Heidi M Munger Clary, MD, MPH336-716-7110
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | Heidi M Munger Clary, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Winston-Salem, NC
By condition
By research site
Related Studies
- A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresPHASE3 · Recruiting · UCB Biopharma SRL · Hawthorne, New York
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPHASE2 · Recruiting · Darcy Krueger · Birmingham, Alabama
- Examining the Effects of Estradiol on Neural and Molecular Response to RewardPHASE4 · Recruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina